Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CERTOLIZUMAB PEGOL Cause Product dose omission in error? 226 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 226 reports of Product dose omission in error have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.2% of all adverse event reports for CERTOLIZUMAB PEGOL.

226
Reports of Product dose omission in error with CERTOLIZUMAB PEGOL
0.2%
of all CERTOLIZUMAB PEGOL reports
0
Deaths
21
Hospitalizations

How Dangerous Is Product dose omission in error From CERTOLIZUMAB PEGOL?

Of the 226 reports, 21 (9.3%) required hospitalization.

Is Product dose omission in error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 226 reports have been filed with the FAERS database.

What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?

Drug ineffective (23,838) Rheumatoid arthritis (17,782) Pain (13,929) Fatigue (11,438) Off label use (10,281) Rash (9,663) Alopecia (9,111) Maternal exposure during pregnancy (9,013) Arthralgia (8,993) Abdominal discomfort (8,615)

What Other Drugs Cause Product dose omission in error?

DUPILUMAB (7,586) TOFACITINIB (2,461) LENALIDOMIDE (618) PALBOCICLIB (592) DIROXIMEL (481) ABALOPARATIDE (457) NIRAPARIB (428) RUXOLITINIB (425) TERIFLUNOMIDE (371) DIMETHYL (308)

Which CERTOLIZUMAB PEGOL Alternatives Have Lower Product dose omission in error Risk?

CERTOLIZUMAB PEGOL vs CERTOPARIN CERTOLIZUMAB PEGOL vs CETIRIZINE CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE CERTOLIZUMAB PEGOL vs CETRIMIDE CERTOLIZUMAB PEGOL vs CETRORELIX

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Product dose omission in error Reports All Drugs Causing Product dose omission in error CERTOLIZUMAB PEGOL Demographics